Advertisement

Topics

EndoCross, Ltd. Company Profile

05:37 EDT 18th June 2018 | BioPortfolio

Privately held EndoCross Ltd., headquartered in Yokneam Israel, and with operations in Amherst, New Hampshire (USA), has developed a proprietary system for the crossing of Chronic Total Occlusion (CTO). Through a combination of a unique balloon catheter design and the incorporation of a novel automated inflation system, the company’s ENABLER Catheter Systems are designed to empower physicians to quickly and easily advance angioplasty guidewires beyond arterial blockages, thus avoiding long and complex procedures or, in the worst case, bypass surgery. It is the expectation of EndoCross management that, in time, the ENABLER Catheter System will be incorporated into the standard treatment options for coronary artery disease, such as angioplasty balloons, atherectomy devices and stents.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

EndoCross, Ltd.

Privately held EndoCross Ltd., headquartered in Yokneam Israel, and with operations in Amherst, New Hampshire (USA), has developed a proprietary system for the crossing of Chronic...

More Information about "EndoCross, Ltd." on BioPortfolio

We have published hundreds of EndoCross, Ltd. news stories on BioPortfolio along with dozens of EndoCross, Ltd. Clinical Trials and PubMed Articles about EndoCross, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EndoCross, Ltd. Companies in our database. You can also find out about relevant EndoCross, Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record